|Articles|July 1, 1999

July 1999
Volume 5
Issue 7

Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease

Author(s)Eva Vivian, PharmD, Anthony Morreale, PharmD, BCPS, MBA, Eric Boyce, PharmD

Download PDF: Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease

Articles in this issue

over 26 years ago

Article

Hospital Expenditures and Utilization: The Impact of HMOs

over 26 years ago

Article

The Cost of Alzheimer's Disease in Managed Care: A Cross-Sectional Study

over 26 years ago

Article

Payor Cost Savings with Endometrial Ablation Therapy

over 26 years ago

Article

The Food and Drug Administration and Atrial Defibrillation Devices

over 26 years ago

Article

Benign Prostatic Hyperplasia: New Concepts for the Millennium

over 26 years ago

Article

Breast Cancer Prevention: The Role of Antiestrogens

over 26 years ago

Article

The Impact of HMOs on Hospital Use and Cost? A Matter of Interpretation

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

December 16th 2025

Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease

Articles in this issue

Newsletter

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

Trending on AJMC

Top 5 Most-Read HIV Articles of 2025

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

The Top 5 Most-Read Multiple Myeloma Content of 2025

Time-Limited Regimens Gain Notice, Offering a Break for Patients With Blood Cancer and Savings for Payers

New Evidence Shows Exercise Could Ease Key Symptoms of Ovarian Cancer